296 related articles for article (PubMed ID: 20959601)
21. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium.
Pouplard C; Amiral J; Borg JY; Vissac AM; Delahousse B; Gruel Y
Br J Haematol; 1997 Nov; 99(2):273-80. PubMed ID: 9375738
[TBL] [Abstract][Full Text] [Related]
22. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia.
Ziporen L; Li ZQ; Park KS; Sabnekar P; Liu WY; Arepally G; Shoenfeld Y; Kieber-Emmons T; Cines DB; Poncz M
Blood; 1998 Nov; 92(9):3250-9. PubMed ID: 9787161
[TBL] [Abstract][Full Text] [Related]
23. Atomic description of the immune complex involved in heparin-induced thrombocytopenia.
Cai Z; Yarovoi SV; Zhu Z; Rauova L; Hayes V; Lebedeva T; Liu Q; Poncz M; Arepally G; Cines DB; Greene MI
Nat Commun; 2015 Sep; 6():8277. PubMed ID: 26391892
[TBL] [Abstract][Full Text] [Related]
24. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
25. Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4.
Jaax ME; Krauel K; Marschall T; Brandt S; Gansler J; Fürll B; Appel B; Fischer S; Block S; Helm CA; Müller S; Preissner KT; Greinacher A
Blood; 2013 Jul; 122(2):272-81. PubMed ID: 23673861
[TBL] [Abstract][Full Text] [Related]
26. Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity.
Nguyen TH; Medvedev N; Delcea M; Greinacher A
Nat Commun; 2017 May; 8():14945. PubMed ID: 28530237
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia.
Horne MK; Hutchison KJ
Am J Hematol; 1998 May; 58(1):24-30. PubMed ID: 9590145
[TBL] [Abstract][Full Text] [Related]
28. Anti-PF4/heparin antibodies are increased in hospitalized patients with bacterial sepsis.
Maharaj S; Chang S
Thromb Res; 2018 Nov; 171():111-113. PubMed ID: 30273811
[TBL] [Abstract][Full Text] [Related]
29. Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
Krauel K; Hackbarth C; Fürll B; Greinacher A
Blood; 2012 Feb; 119(5):1248-55. PubMed ID: 22049520
[TBL] [Abstract][Full Text] [Related]
30. Studies of the anti-platelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens.
Selleng K; Schütt A; Selleng S; Warkentin TE; Greinacher A
Transfusion; 2010 Jan; 50(1):32-9. PubMed ID: 19709391
[TBL] [Abstract][Full Text] [Related]
31. Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis.
Padmanabhan A; Jones CG; Bougie DW; Curtis BR; McFarland JG; Wang D; Aster RH
Blood; 2015 Jan; 125(1):155-61. PubMed ID: 25342714
[TBL] [Abstract][Full Text] [Related]
32. Development of a high-yield expression and purification system for platelet factor 4.
Huynh A; Arnold DM; Moore JC; Smith JW; Kelton JG; Nazy I
Platelets; 2018 May; 29(3):249-256. PubMed ID: 29172900
[TBL] [Abstract][Full Text] [Related]
33. Studies of the immune response in heparin-induced thrombocytopenia.
Warkentin TE; Sheppard JA; Moore JC; Cook RJ; Kelton JG
Blood; 2009 May; 113(20):4963-9. PubMed ID: 19144981
[TBL] [Abstract][Full Text] [Related]
34. Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
Blank M; Cines DB; Arepally G; Eldor A; Afek A; Shoenfeld Y
Clin Exp Immunol; 1997 May; 108(2):333-9. PubMed ID: 9158107
[TBL] [Abstract][Full Text] [Related]
35. Association of natural anti-platelet factor 4/heparin antibodies with periodontal disease.
Greinacher A; Holtfreter B; Krauel K; Gätke D; Weber C; Ittermann T; Hammerschmidt S; Kocher T
Blood; 2011 Aug; 118(5):1395-401. PubMed ID: 21659541
[TBL] [Abstract][Full Text] [Related]
36. B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia.
Zheng Y; Wang AW; Yu M; Padmanabhan A; Tourdot BE; Newman DK; White GC; Aster RH; Wen R; Wang D
Blood; 2014 Feb; 123(6):931-4. PubMed ID: 24357731
[TBL] [Abstract][Full Text] [Related]
37. Dynamic antibody-binding properties in the pathogenesis of HIT.
Sachais BS; Litvinov RI; Yarovoi SV; Rauova L; Hinds JL; Rux AH; Arepally GM; Poncz M; Cuker A; Weisel JW; Cines DB
Blood; 2012 Aug; 120(5):1137-42. PubMed ID: 22577175
[TBL] [Abstract][Full Text] [Related]
38. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.
Greinacher A; Pötzsch B; Amiral J; Dummel V; Eichner A; Mueller-Eckhardt C
Thromb Haemost; 1994 Feb; 71(2):247-51. PubMed ID: 8191407
[TBL] [Abstract][Full Text] [Related]
39. Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT.
Kowalska MA; Krishnaswamy S; Rauova L; Zhai L; Hayes V; Amirikian K; Esko JD; Bougie DW; Aster RH; Cines DB; Poncz M
Blood; 2011 Sep; 118(10):2882-8. PubMed ID: 21772054
[TBL] [Abstract][Full Text] [Related]
40. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
